“We can no longer rely on the US as our primary market. Instead, the EU itself must become willing to pay for innovation and thereby create the conditions for a competitive life science sector here at home,” says Jessica Martinsson, CEO of SwedenBIO. nordiclifescience.org/new-trump-ca...

"Denmark and Sweden could not only continue to be innovation drivers and help realize the region’s own potential, but together we could also position ourselves for a place in the driving seat when it comes to the more strategic European ambitions." writes @mediconvalley.bsky.social

“This support is a very strong vote of confidence in the ability of Swedish and Nordic life sciences to build and compete globally," says Reagan Jarvis, CEO, Anocca. nordiclifescience.org/anocca-raise...

Even though many have tried and few succeeded in the quest to find viable treatments for neurodegenerative diseases, Nordic drug developers continue to take different approaches to crack the riddle. nordiclifescience.org/global-healt...

"In the long run, the EU’s life science industry will likely need to reduce its dependence on the U.S. to mitigate the impact of extraordinary events like these. We are being thrown into a chaotic situation reminiscent of the COVID pandemic,” states SwedenBIO nordiclifescience.org/no-us-market...

“Our study shows how different cell types arise from stem cells in the embryo and how they are organized to create important structures in the brain,” stated Emma Andersson, docent at the Department of Cell and Molecular Biology, @ki.se

“Each heart contraction is caused by an influx of calcium into the heart cell. Our agents work by increasing the sensitivity of the heart muscle to this calcium, so that the contraction becomes stronger.” – Patrik Strömberg #AnaCardioAB

"EsoBiotec will accelerate and expand the impact of our recent investments and marks a major step forward in realizing our ambition to harness the full potential of cell therapy,” says Susan Galbraith, Executive Vice President, Oncology Haematology R&D, AstraZeneca.

Overall, 2025 is anticipated to be a year of significant progress, with three key themes standing out, writes Marjo Puumalainen, SwedenBIO.

“Obesity is the most fascinating lens through which to study life – it spans everything from the micro level of cellular metabolism to the macro level of behavior and society,” says Kirsi Pietiläinen. @helsinki.fi

✊ #StandUpForScience! 🧪 #ScienceIsPeople... People in solidarity all over the world!

"The goal is to end the war, establish a just peace, and provide Ukraine with a future perspective for generations to come. We stand by this cause with our voices," writes the Nobel Prize laureates.

"To be able to compete globally, we must concentrate our efforts in Europe and build on existing strongholds and clusters of excellence," writes Niels Abel Bonde @mediconvalley.bsky.social

This in vivo study with a novel nasal influenza vaccine candidate is part of Abera Bioscience's collaboration with CEPI.

“Bacterial AMR is such a significant global health issue that we must speed up innovation and try new ways of working together,” says Marianne Holm, Vice President, Infectious diseases, Novo Nordisk Foundation.

Christopher Goodnow @garvaninstitute.bsky.social and David Nemazee @scripps.edu discovered important mechanisms that prevent B cells from attacking the body’s own tissues in autoimmune disease. This could pave the way for new treatments for rheumatoid arthritis, lupus and multiple sclerosis.

The team behind NordicRWE believe the possibilities of Real-World Evidence are obvious, but access to and sharing data between the Nordic countries are hurdles that need to be overcome.

The investment in Canada will create more than 700 high-skilled jobs, across all areas of the business. @astrazeneca.bsky.social

“This is what scientific progress in medicine is intended to achieve: improving the life of patients, in particular those with rare diseases, by providing innovative therapeutic options.” – Fredrik Sjöö Nordic Region CSL Behring #GeneTherapy

"This open-source approach enables researchers to utilize our data and publish their findings, enabling scientific progress,” says Cecilia Lindskog #TheHumanProteinAtlas

Hopeful! Preclinical data have shown a marked reduction of endometriotic lesions and pain following treatment with vipoglanstat. @gesyntapharma.bsky.social #endometriosis

"This MOU will strengthen formally that relationship, building a bridge between the innovative life science communities in Sweden and California,” says Joe Panetta, president emeritus of Biocom California.

According to Professor Matthias Christandl, Leader of the Quantum for Life Centre #CopenhagenUniversity, the potential of quantum computing within life sciences is enormous and in order to take the lead, investments in both quantum hardware and software is essential.

Go Finland! "A strong collective will has emerged, uniting various stakeholders in a shared mission to build something remarkable," writes Alexandra Peth, Finnish Bioindustries.

"I think what underlies our achievements is an incredible ecosystem in Sweden. We’re very excited now with the capital that we have obtained to advance our lead program into late stage clinical development for idiopathic pulmonary fibrosis," says Ahmed Mousa, CEO, Vicore Pharma.

"Fifteen years ago, I predicted that AI would play a central role in healthcare, and today, that prediction is becoming reality. Across global projects, I’ve seen AI revolutionize how we diagnose, treat, and manage complex health conditions," writes Christian Guttmann in our latest issue.

"We are very likely only at the beginning of a scientific era that will yield a range of new protein-based technologies and strategies that almost certainly will make a major difference to how we target and treat diseases in the future." @uio.no

“I now plan to focus more on what matters the most to me, like collaborating closely with my students and postdocs and dedicating myself to the most meaningful and exciting research projects," says Nobel Prize laureate David Baker @uwischool.bsky.social Howard Hughes Medical Institute.

Attending The Future of Health @nobelprize.bsky.social On stage: 3 Nobel Prize laureates, all interviewed by NLS 🤩

"Share your findings, don’t be secretive. When you share in a community, ideas pop up. Brainstorming and collaborating are fuels for success and that makes science fun.” – Victor Ambros @umasspress.bsky.social

How then do we continue to strengthen the research and innovation environment so that it fosters more Nobel Prize rewards in Medicon Valley? @mediconvalley.bsky.social

IonQ has set up in Gothenburg, primarily through a new development center at AstraZeneca BioVentureHub. Learn more about quantum computing in the Denmark in our latest issue of the magazine (out now: nordiclifescience.org/subscribe/) and in Finland here: nordiclifescience.org/quantum-comp...

In today’s rapidly shifting global landscape, it’s clear that the future of humanity hinges on how we invest in people, particularly leaders, right now. #UnlockingEve

"I’m very happy to see that the Swedish strategy focuses on collaboration and also on the Nordic perspective," says Niels Abel Bonde @mediconvalley.bsky.social

"There is today an urgency to develop new prophylactic vaccines which could play a critical role in preventing high-threat bacterial infections associated with AMR." #WAAW2024 #AMR

There are a number of issues that need to be kept in mind for successful licensing agreement. NLS asked Malin Ohlin and Christoffer Nordin at the Nordic law firm Vinge, to share their advice and insights.

"Roughly half of the infections in healthcare setting are related to medical devices. This issue not only affects patients but also jeopardizes the future efficacy of antibiotics," says Christine Lind #Bactiguard #WAAW2024 #AMR

"We believe that introducing biosimilars for core oncology treatments, particularly PD-1 inhibitors, plays a critical role in advancing cancer care,” says Martin Åmark, CEO, Xbrane.

In Sweden, recent debate and criticism regarding approved multiple myeloma treatments has shone the spotlight on IMiDs and their effects. NLS asked Fredrik Schjesvold, MD, PhD, founder and leader of Oslo Myeloma Center, Oslo University Hospital, about these drugs and the ongoing debate.

All over the Nordics the innovative power is gearing up to put new products, therapies, and preventive measures on the market that will tackle AMR from various angles. #WAAW2024 nordiclifescience.org/waaw-mini-in...

Norwegian company AdjuTec’s novel antibiotic resistance breakers may help to facilitate reduced use of antibiotics – and the company is now ready to test its product in humans. #WAAW2024 nordiclifescience.org/waaw-intervi...

NordForsk has decided to fund six Nordic research networks that will apply for EU calls in the field of antimicrobial resistance (AMR). #WAAW2024 nordiclifescience.org/new-nordic-c...

The life science innovation gap between the EU and its global competitors continues to widen while the number of EU regulations affecting the industry is rising. Are we heading in the right direction, writes Jessica Martinsson, SwedenBIO. nordiclifescience.org/navigating-a...

In 1986, Jens Juul Holst and his research team discovered glucagon-like peptide 1, known to most as GLP-1. “There will be a lot of surplus money going to science,” he predicts. nordiclifescience.org/exclusive-in...